187 related articles for article (PubMed ID: 32277101)
1. Comparison of commercially available whole-genome sequencing kits for variant detection in circulating cell-free DNA.
Mauger F; Horgues C; Pierre-Jean M; Oussada N; Mesrob L; Deleuze JF
Sci Rep; 2020 Apr; 10(1):6190. PubMed ID: 32277101
[TBL] [Abstract][Full Text] [Related]
2. Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort.
Chen X; Chang CW; Spoerke JM; Yoh KE; Kapoor V; Baudo C; Aimi J; Yu M; Liang-Chu MMY; Suttmann R; Huw LY; Gendreau S; Cummings C; Lackner MR
Clin Cancer Res; 2019 Apr; 25(7):2254-2263. PubMed ID: 30617129
[TBL] [Abstract][Full Text] [Related]
3. Single Color Multiplexed ddPCR Copy Number Measurements and Single Nucleotide Variant Genotyping.
Wood-Bouwens CM; Ji HP
Methods Mol Biol; 2018; 1768():323-333. PubMed ID: 29717451
[TBL] [Abstract][Full Text] [Related]
4. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer.
Cario CL; Chen E; Leong L; Emami NC; Lopez K; Tenggara I; Simko JP; Friedlander TW; Li PS; Paris PL; Carroll PR; Witte JS
BMC Cancer; 2020 Aug; 20(1):820. PubMed ID: 32859160
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.
Stankunaite R; George SL; Gallagher L; Jamal S; Shaikh R; Yuan L; Hughes D; Proszek PZ; Carter P; Pietka G; Heide T; James C; Tari H; Lynn C; Jain N; Portela LR; Rogers T; Vaidya SJ; Chisholm JC; Carceller F; Szychot E; Mandeville H; Angelini P; Jesudason AB; Jackson M; Marshall LV; Gatz SA; Anderson J; Sottoriva A; Chesler L; Hubank M
Eur J Cancer; 2022 Feb; 162():209-220. PubMed ID: 34933802
[TBL] [Abstract][Full Text] [Related]
6. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
[TBL] [Abstract][Full Text] [Related]
7. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
[TBL] [Abstract][Full Text] [Related]
8. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment.
Widman AJ; Shah M; Frydendahl A; Halmos D; Khamnei CC; Øgaard N; Rajagopalan S; Arora A; Deshpande A; Hooper WF; Quentin J; Bass J; Zhang M; Langanay T; Andersen L; Steinsnyder Z; Liao W; Rasmussen MH; Henriksen TV; Jensen SØ; Nors J; Therkildsen C; Sotelo J; Brand R; Schiffman JS; Shah RH; Cheng AP; Maher C; Spain L; Krause K; Frederick DT; den Brok W; Lohrisch C; Shenkier T; Simmons C; Villa D; Mungall AJ; Moore R; Zaikova E; Cerda V; Kong E; Lai D; Malbari MS; Marton M; Manaa D; Winterkorn L; Gelmon K; Callahan MK; Boland G; Potenski C; Wolchok JD; Saxena A; Turajlic S; Imielinski M; Berger MF; Aparicio S; Altorki NK; Postow MA; Robine N; Andersen CL; Landau DA
Nat Med; 2024 Jun; 30(6):1655-1666. PubMed ID: 38877116
[TBL] [Abstract][Full Text] [Related]
9. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
[TBL] [Abstract][Full Text] [Related]
10. KoVariome: Korean National Standard Reference Variome database of whole genomes with comprehensive SNV, indel, CNV, and SV analyses.
Kim J; Weber JA; Jho S; Jang J; Jun J; Cho YS; Kim HM; Kim H; Kim Y; Chung O; Kim CG; Lee H; Kim BC; Han K; Koh I; Chae KS; Lee S; Edwards JS; Bhak J
Sci Rep; 2018 Apr; 8(1):5677. PubMed ID: 29618732
[TBL] [Abstract][Full Text] [Related]
11. Lightning-fast genome variant detection with GROM.
Smith SD; Kawash JK; Grigoriev A
Gigascience; 2017 Oct; 6(10):1-7. PubMed ID: 29048532
[TBL] [Abstract][Full Text] [Related]
12. Performance of copy number variants detection based on whole-genome sequencing by DNBSEQ platforms.
Rao J; Peng L; Liang X; Jiang H; Geng C; Zhao X; Liu X; Fan G; Chen F; Mu F
BMC Bioinformatics; 2020 Nov; 21(1):518. PubMed ID: 33176676
[TBL] [Abstract][Full Text] [Related]
13. Identification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA.
Chen Y; George AM; Olsson E; Saal LH
Methods Mol Biol; 2018; 1768():303-322. PubMed ID: 29717450
[TBL] [Abstract][Full Text] [Related]
14. eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA.
Mizuno K; Akamatsu S; Sumiyoshi T; Wong JH; Fujita M; Maejima K; Nakano K; Ono A; Aikata H; Ueno M; Hayami S; Yamaue H; Chayama K; Inoue T; Ogawa O; Nakagawa H; Fujimoto A
Sci Rep; 2019 Oct; 9(1):15017. PubMed ID: 31641155
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
Valpione S; Campana L
Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
[TBL] [Abstract][Full Text] [Related]
17. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
